Key points from article :
Update on Ambrosia trial that gives blood plasma from under 25s to older people.
Recipients have shown improvements in biomarkers related to cancer, Alzheimer’s disease and heart disease.
Blood tests conducted before and a month after plasma treatment:
- levels of carcinoembryonic antigens fell by around 20 per cent
- 10 per cent fall in blood cholesterol levels
- 20 per cent fall in the level of amyloids
Improvements seen in one participant with early onset Alzheimer’s.
Paid trial and therefore no placebo group.